Chemical synthesis of the ATAD2 bromodomain

被引:14
|
作者
Creech, Gardner S. [1 ]
Paresi, Chelsea [2 ,3 ]
Li, Yue-Ming [2 ,3 ]
Danishefsky, Samuel J. [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, Bioorgan Chem Lab, New York, NY 10065 USA
[2] Cornell Univ, Weill Grad Sch Med Sci, Dept Pharmacol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA
[4] Columbia Univ, Dept Chem, New York, NY 10027 USA
基金
美国国家卫生研究院;
关键词
solid-phase peptide synthesis; desulfurization; peptide retrosynthesis; ANDROGEN RECEPTOR; COREGULATOR ANCCA; LIGATION; COACTIVATOR; PROTEINS; BREAST; CANCER; GENES; IDENTIFICATION; PEPTIDES;
D O I
10.1073/pnas.1400556111
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Due to the emerging importance of the bromodomain binding region in the study of epigenetic effectors and the vast implications for a wide variety of human disease, the bromodomain region of human ATPase family AAA+ (ATPases associated with diverse cellular activities) domain-containing protein 2 (ATAD2) was targeted for chemical synthesis. The ATAD2 bromodomain (130 aa) was divided into five strategic fragments to be assembled using native chemical ligation with a focus on maximal convergency and efficiency. The fragments were assembled with one cysteine and three thioleucine ligations, unveiling the native alanine and leucine amino acids at the ligation points following metal-free dethiylation. Synthetic highlights of the study are a photolabile dimethoxynitrobenzyl-protected glutamic acid side chain used to impede hydrolysis of the C-terminal Glu-thioester, a thiazolidine-protected thioleucine, and an efficient assembly of three fragments in a single reaction vessel with dual-mode kinetic-standard chemical ligation. With a focus on material throughput and convergency, the five peptide fragments were assembled into the native ATAD2 bromodomain region with a total of three HPLC events in 8% overall yield from the fragments.
引用
收藏
页码:2891 / 2896
页数:6
相关论文
共 50 条
  • [1] A Chemical Probe for the ATAD2 Bromodomain
    Bamborough, Paul
    Chung, Chun-wa
    Demont, Emmanuel H.
    Furze, Rebecca C.
    Bannister, Andrew J.
    Che, Ka Hing
    Diallo, Hawa
    Douault, Clement
    Grandi, Paola
    Kouzarides, Tony
    Michon, Anne-Marie
    Mitchell, Darren J.
    Prinjha, Rab K.
    Rau, Christina
    Robson, Samuel
    Sheppard, Robert J.
    Upton, Richard
    Watson, Robert J.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (38) : 11382 - 11386
  • [2] Genomic alteration of bromodomain protein ATAD2 in cancer
    Takeda, Tomoyo
    Matsumura, Yuta
    Nagasaki, Hirotoshi
    Eguchi, Ken
    Takatsuka, Miki
    Shinkai, Yoichi
    Nakagawa, Hiroyuki
    Kawashima, Hitoshi
    Ueno, Hiroyuki
    Li, Chiang J.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [3] Fragment-Based Screening of the Bromodomain of ATAD2
    Harner, Mary J.
    Chauder, Brian A.
    Phan, Jason
    Fesik, Stephen W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (22) : 9687 - 9692
  • [4] Exploring ATAD2 bromodomain function in the dynamic epigenetic landscape
    Malone, Kiera
    Glass, Karen
    [J]. FASEB JOURNAL, 2022, 36
  • [5] Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain
    Evans, Chiara M.
    Phillips, Margaret
    Malone, Kiera L.
    Tonelli, Marco
    Cornilescu, Gabriel
    Cornilescu, Claudia
    Holton, Simon J.
    Gorjanacz, Matyas
    Wang, Liping
    Carlson, Samuel
    Gay, Jamie C.
    Nix, Jay C.
    Demeler, Borries
    Markley, John L.
    Glass, Karen C.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [6] Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain
    Gay, Jamie C.
    Eckenroth, Brian E.
    Evans, Chiara M.
    Langini, Cassiano
    Carlson, Samuel
    Lloyd, Jonathan T.
    Caflisch, Amedeo
    Glass, Karen C.
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2019, 87 (02) : 157 - 167
  • [7] Histone H4 acetyllysine coordination by ATAD2 bromodomain
    Phillips, Margaret
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2021, 77 : A282 - A282
  • [8] Potent and isoform-selective ATAD2 bromodomain inhibitor with unprecedented chemical structure and mode of action
    Fernandez-Montalvan, Amaury E.
    Berger, Markus
    Kuropka, Benno
    Koo, Seong Joo
    Badock, Volker
    Weiske, Joerg
    Holton, Simon J.
    Chaikuad, Apirat
    Diaz-Saez, Laura
    Bennett, James
    Federov, Oleg
    Huber, Kilian
    Centrella, Paolo
    Clark, Matthew A.
    Dumelin, Christoph E.
    Sigel, Eric A.
    Soutter, Holly S.
    Troast, Dawn M.
    Zhang, Ying
    Cuozzo, John W.
    Keefe, Anthony D.
    Roche, Didier
    Rodeschini, Vincent
    Huebner, Jan
    Weinmann, Hilmar
    Hartung, Ingo V.
    Gorjanacz, Matyas
    [J]. CANCER RESEARCH, 2017, 77
  • [9] Disulfide bridge formation contributes to histone ligand recognition by the ATAD2 bromodomain
    Evans, Chiara
    Gay, Jamie
    Eckenroth, Brian E.
    Carlson, Samuel
    Lloyd, Jonathan T.
    Glass, Karen C.
    [J]. FASEB JOURNAL, 2018, 32 (01):
  • [10] Exploring ATAD2 Bromodomain Structure And Function Differences In The Dynamic Epigenetic Landscape
    Malone, Kiera
    Glass, Karen
    Nix, Jay
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2022, 78 : A35 - A35